2013 annual financial data
Viking Therapeutics 2013 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -101,076 USD and net income was -146,247 USD.
Operating cash flow was -78,235 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -101,076 USD
- Net income
- -146,247 USD
- Operating cash flow
- -78,235 USD